Immunotherapeutic efficacy of a Lactobacillus casei lysate as an adjuvant combined with a heated-4T1 mammary carcinoma cell lysate in a murine model of breast cancer

1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5-29.10.3322/caac.2125425559415SiegelRLMillerKDJemalACancer statistics 2015CA Cancer J Clin20156552925559415Open DOISearch in Google Scholar

2DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014; 64:52-62.2411456810.3322/caac.21203DeSantisCMaJBryanLJemalABreast cancer statistics 2013CA Cancer J Clin201464526224114568Search in Google Scholar

3Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 386-405.10.1093/jnci/djr54122271773Howard-AndersonJGanzPABowerJEStantonALQuality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic reviewJ Natl Cancer Inst201210438640522271773Open DOISearch in Google Scholar

4Finn OJ. Cancer immunology. New Engl J Med. 2008; 358:2704-15.10.1056/NEJMra072739FinnOJCancer immunologyNew Engl J Med200835827041518565863Open DOISearch in Google Scholar

5Dougan M, Dranoff G. Immunotherapy of cancer. In: Wang R-F, editor. Innate immune regulation and cancer immunotherapy. New York: Springer; 2012. p. 391-414.DouganMDranoffGImmunotherapy of cancerWangR-FInnate immune regulation and cancer immunotherapyNew YorkSpringer201239141410.1007/978-1-4419-9914-6_22Search in Google Scholar

6Dougan M, Dranoff G. Immune therapy for cancer. Annu Rev Immunol. 2009; 27:83-117.10.1146/annurev.immunol.021908.13254419007331DouganMDranoffGImmune therapy for cancerAnnu Rev Immunol2009278311719007331Open DOISearch in Google Scholar

7Mueller M, Reichardt W, Koerner J, Groettrup M. Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice. J Controlled Release. 2012; 162:159-66.10.1016/j.jconrel.2012.06.015MuellerMReichardtWKoernerJGroettrupMCoencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceJ Controlled Release20121621596622709589Open DOISearch in Google Scholar

8González FE, Gleisner A, Falcόn-Beas F, Osorio F, Lόpez MN, Salazar-Onfray F. Tumor cell lysates as immunogenic sources for cancer vaccine design. Hum Vaccin Immunother. 2014; 10:3261-9.10.4161/21645515.2014.98299625625929GonzálezFEGleisnerAFalcόnBeasFOsorioFLόpezMNSalazar-OnfrayFTumor cell lysates as immunogenic sources for cancer vaccine designHum Vaccin Immunother20141032619451408925625929Open DOISearch in Google Scholar

9Chiang CL-L, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: where are we? Vaccines. 2015; 3: 344-72.10.3390/vaccines302034426343191ChiangCL-LCoukosGKandalaftLEWhole tumor antigen vaccines:where are we?Vaccines2015334472449435626343191Open DOISearch in Google Scholar

10Guo QT, Li X, Yang Y, Wei J, Zhao Q, Luo FR, et al. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly (L-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol. 2014; 10:227-37.2473833110.1166/jbn.2014.1785GuoQTLiXYangYWeiJZhaoQLuoFRet alEnhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly (L-lactide) grafted polyethylenimine cationic nanoparticlesJ Biomed Nanotechnol2014102273724738331Search in Google Scholar

11Motlagh BM, Ahangaran NA, Froushani SMA. Calcitriol modulates the effects of bone marrow-derived mesenchymal stem cells on macrophage functions. Iran J Basic Med Sci. 2015; 18:672-76.26351558MotlaghBMAhangaranNAFroushaniSMACalcitriol modulates the effects of bone marrow-derived mesenchymal stem cells on macrophage functionsIran J Basic Med Sci20151867276Search in Google Scholar

12Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. In: Böze Z, editor. Bioactive components of milk. Adv Exp Med Biol vol. 606. New York: Springer; 2008. p. 423-54.10.1007/978-0-387-74087-4_17GillHPrasadJProbiotics, immunomodulation, and health benefitsBöszeZBioactive components of milk. Adv Exp Med Biol606New YorkSpringer200842354Open DOISearch in Google Scholar

13Dong H, Rowland I, Thomas LV, Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Clin Nutr. 2013; 52:1853-63.10.1007/s00394-012-0487-1DongHRowlandIThomasLVYaqoobPImmunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteersEur J Clin Nutr201352185363Open DOISearch in Google Scholar

14Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol. 1998; 41:133-40.10.1016/S0168-1605(98)00046-49704862MatsuzakiTImmunomodulation by treatment with Lactobacillus casei strain ShirotaInt J Food Microbiol19984113340Open DOISearch in Google Scholar

15Hwang JW, Baek Y-M, Yang KE, Yoo H-S, Cho C-K, Lee Y-W, et al. Lactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-kB and mTOR-mediated signaling. Integr Cancer Ther. 2013; 12:165-73.2250559510.1177/1534735412442380HwangJWBaekY-MYangKEYooH-SChoC-KLeeY-Wet alLactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-kB and mTOR-mediated signalingIntegr Cancer Ther2013121657322505595Search in Google Scholar

16Kim S-N, Lee WM, Park KS, Kim JB, Han DJ, Bae J. The effect of Lactobacillus casei extract on cervical cancer cell lines. Contemp Oncol (Pozn). 2015; 19: 306-12.26557779KimS-NLeeWMParkKSKimJBHanDJBaeJThe effect of Lactobacillus casei extract on cervical cancer cell linesContemp Oncol (Pozn)2015193061210.5114/wo.2014.45292463129626557779Search in Google Scholar

17Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res. 2000; 60:3435-9.10910053HuangQHuJKLohrFZhangLBraunRLanzenJet alHeat-induced gene expression as a novel targeted cancer gene therapy strategyCancer Res20006034359Search in Google Scholar

18Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol. 2006; 60:12-21.10.1002/ana.2091316802293SteinmanLZamvilSSHow to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisAnn Neurol200660122116802293Open DOISearch in Google Scholar

19Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Cell Immunol. 2009; 257:23-31.10.1016/j.cellimm.2009.02.002DelirezhNMoazzeniSMShokriFShokrgozarMAAtriMKokhaeiPAutologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitroCell Immunol2009257233119306994Open DOISearch in Google Scholar

20Lebendiker M. The Wolfson Centre for Applied Structural Biology. Bacterial protein extraction - mini scale - Sonication. 2002. Available at http://wolfson.huji.ac.il/purification/TagProteinPurif/Lysis_Bacterial_Cells.html Accessed March 15, 2016.LebendikerMThe Wolfson Centre for Applied Structural BiologyBacterial protein extraction - mini scale - Sonication2002Available athttp://wolfson.huji.ac.il/purification/TagProteinPurif/Lysis_Bacterial_Cells.htmlMarch152016Search in Google Scholar

21Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest. 2014; 43:54-68.10.3109/08820139.2013.82526924063549Abtahi FroushaniSMDelirezhNHobbenaghiRMosayebiGSynergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosisImmunol Invest201443546824063549Open DOISearch in Google Scholar

22Jahangiri S, Abtahi Froushani SM, Delirezh N. Combination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancer. Turk J Med Sci. 2016; 46:518-23.10.3906/sag-1410-6127511520JahangiriSAbtahi FroushaniSMDelirezhNCombination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancerTurk J Med Sci2016465182327511520Open DOISearch in Google Scholar

23Bausero MA, Page DT, Osinaga E, Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumor Biol. 2004; 25: 243-51.10.1159/000081387BauseroMAPageDTOsinagaEAseaASurface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasisTumor Biol20042524351176448915627887Open DOISearch in Google Scholar

24Vanbuskirk A, Crump BL, Margoliash E, Pierce S. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. J Exp Med. 1989; 170:1799-809.10.1084/jem.170.6.17992584924VanbuskirkACrumpBLMargoliashEPierceSA peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock familyJ Exp Med1989170179980921895242584924Open DOISearch in Google Scholar

25Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015; 16: 343-53.2578968410.1038/ni.3123IwasakiAMedzhitovRControl of adaptive immunity by the innate immune systemNat Immunol20151634353450749825789684Search in Google Scholar

26Tanimura N, Miyake K. Toll like receptors. In: Taniguchi N et al., editors. Glycoscience: biology and medicine. Tokyo: Springer; 2015. p. 707-12.TanimuraNMiyakeKToll like receptorsTaniguchiNet al Glycoscience:biology and medicineTokyoSpringer20157071210.1007/978-4-431-54841-6_142Search in Google Scholar

27Mesa C, Fernández LE. Challenges facing adjuvants for cancer immunotherapy. Immunol Cell Biol. 2004; 82:644-50.10.1111/j.0818-9641.2004.01279.x15550123MesaCFernándezLEChallenges facing adjuvants for cancer immunotherapyImmunol Cell Biol2004826445015550123Open DOISearch in Google Scholar

28Dredge K, Marriott JB, Todryk SM, Dalgleish AG. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother. 2002; 51:521-31.10.1007/s00262-002-0309-z12384803DredgeKMarriottJBTodrykSMDalgleishAGAdjuvants and the promotion of Th1-type cytokines in tumour immunotherapyCancer Immunol Immunother2002515213112384803Open DOISearch in Google Scholar

29Bobanga ID, Petrosiute A, Huang AY. Chemokines as cancer vaccine adjuvants. Vaccines. 2013; 1:444-62.2496709410.3390/vaccines1040444BobangaIDPetrosiuteAHuangAYChemokines as cancer vaccine adjuvantsVaccines2013144462406704424967094Search in Google Scholar

30Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011; 10:499-511.2150664710.1586/erv.10.174BodeCZhaoGSteinhagenFKinjoTKlinmanDMCpG DNA as a vaccine adjuvantExpert Rev Vaccines201110499511310843421506647Search in Google Scholar

31Lenoir M, del Carmen S, Cortes-Perez NG, Lozano-Ojalvo D, Muñoz-Provencio D, Chain F, et al. Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol. 2016:1-12.LenoirMdel CarmenSCortes-PerezNGLozano-OjalvoDMuñoz-ProvencioDChainFet alLactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancerJ Gastroenterol201611210.1007/s00535-015-1158-926749362Search in Google Scholar

32Kaga C, Takagi A, Kano M, Kado S, Kato I, Sakai M, et al. Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer. Cancer Sci. 2013; 104:1508-14.2399248610.1111/cas.12268KagaCTakagiAKanoMKadoSKatoISakaiMet alLactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancerCancer Sci2013104150814765653223992486Search in Google Scholar

33Aragόn F, Carino S, Perdigόn G, de Moreno de LeBlanc A. Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431. J Immunotherapy. 2015; 38:185-96.10.1097/CJI.0000000000000079AragόnFCarinoSPerdigόnGde Moreno de LeBlancAInhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431J Immunotherapy2015381859625962107Open DOISearch in Google Scholar

34Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, et al. Safety of targeting tumor endothelial cell antigens. J Trans Med. 2016; 14:1.WagnerSCRiordanNHIchimTESzymanskiJMaHPerezJAet alSafety of targeting tumor endothelial cell antigensJ Trans Med201614110.1186/s12967-016-0842-8483003427071457Search in Google Scholar

35Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1994; 180:35-42.800659310.1084/jem.180.1.35CouliePGBrichardVVan PelAWölfelTSchneiderJTraversariCet alA new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasJ Exp Med1994180354221915748006593Search in Google Scholar

36Babu A, Templeton AK, Munshi A, Ramesh R. Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomater. 2013; 2013:14.BabuATempletonAKMunshiARameshRNanoparticle-based drug delivery for therapy of lung cancer:progress and challengesJ Nanomater201320131410.1155/2013/863951Search in Google Scholar

37Pham VQ, Nguyen ST, Mai TT, Phan NK, Van Pham P. Breast cancer tumor growth is efficiently inhibited by dendritic cell transfusion in murine model. Biomed Res Ther. 2014; 1:85-92.PhamVQNguyenSTMaiTTPhanNKVanPhamPBreast cancer tumor growth is efficiently inhibited by dendritic cell transfusion in murine modelBiomed Res Ther20141859210.7603/s40730-014-0014-5Search in Google Scholar

38Levine B, Vaz N. Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. Int Arch Allergy Immunol. 1970; 39:156-7110.1159/000230343LevineBVazNEffect of combinations of inbred strain antigen and antigen dose on immune responsiveness and reagin production in the mouseInt Arch Allergy Immunol197039156714097264Open DOISearch in Google Scholar